These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24684416)

  • 1. A measure of chronic quality of life predicts socioeconomic and medical outcomes in psoriasis patients.
    Kim GE; Seidler E; Kimball AB
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):249-254. PubMed ID: 24684416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Age at Diagnosis on Chronic Quality of Life and Long-Term Outcomes of Individuals with Psoriasis.
    Kim GE; Seidler E; Kimball AB
    Pediatr Dermatol; 2015; 32(5):656-62. PubMed ID: 25556559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relative impact of psoriasis and obesity on socioeconomic and medical outcomes in psoriasis patients.
    Kim GE; Seidler E; Kimball AB
    J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):216-21. PubMed ID: 23347229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of psoriasis on quality of life in Iran.
    Aghaei S; Moradi A; Ardekani GS
    Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
    Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
    JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
    Langenbruch A; Radtke MA; Gutknecht M; Augustin M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secukinumab sustains early patient-reported outcome benefits through 1 year: Results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept.
    Strober B; Gottlieb AB; Sherif B; Mollon P; Gilloteau I; McLeod L; Fox T; Mordin M; Gnanasakthy A; Papavassilis C; Lebwohl MG
    J Am Acad Dermatol; 2017 Apr; 76(4):655-661. PubMed ID: 28087133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
    Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
    J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
    Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
    Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis.
    Schmitt J; Küster D
    Arch Dermatol Res; 2015 Jul; 307(5):451-3. PubMed ID: 25940274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring quality of life in patients with psoriasis using the Arabic version for Morocco of the Dermatology Life Quality Index.
    Khoudri I; Lamchahab FZ; Ismaili N; Senouci K; Hassam B; Abouqal R
    Int J Dermatol; 2013 Jul; 52(7):795-802. PubMed ID: 23488573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable dermatology life quality index improvements in patients on biologics associated with psoriasis areas and severity index: a longitudinal study.
    Chaptini C; Quinn S; Marshman G
    Australas J Dermatol; 2016 Aug; 57(3):e72-5. PubMed ID: 26010650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between quality of life and the severity of psoriasis in Turkey.
    Çakmur H; Derviş E
    Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis.
    Mazzotti E; Picardi A; Sampogna F; Sera F; Pasquini P; Abeni D;
    Br J Dermatol; 2003 Aug; 149(2):318-22. PubMed ID: 12932238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis.
    Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K;
    Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study.
    Cozzani E; Linder D; Burlando M; Gallo F; Sampogna F; Bruzzone M; Tacchino C; Drago F; Parodi A
    Eur J Dermatol; 2018 Jun; 28(3):332-337. PubMed ID: 29789272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of patient and physician treatment satisfaction in moderate-to-severe psoriasis: a multinational survey of psoriasis patients.
    Teeple A; Villacorta R; PharmD SL; Fakharzadeh S; Lucas J; PhD NL
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years.
    van Geel MJ; Maatkamp M; Oostveen AM; de Jong EM; Finlay AY; van de Kerkhof PC; Seyger MM
    Br J Dermatol; 2016 Jan; 174(1):152-7. PubMed ID: 26361284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.
    Rencz F; Poór AK; Péntek M; Holló P; Kárpáti S; Gulácsi L; Szegedi A; Remenyik É; Hidvégi B; Herszényi K; Jókai H; Beretzky Z; Brodszky V
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):783-790. PubMed ID: 29114942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.